Oppenheimer & CO Inc Pacific Biosciences Of California, Inc. Transaction History

Oppenheimer & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$7.94 - $12.02 $4,509 - $6,827	-568 Reduced 1.28%	43,920 $508,000
Q4 2022 Feb 07, 2023	SELL	$5.67 - $11.2 $14,787 - $29,209	-2,608 Reduced 5.54%	44,488 $363,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $106,487 - $232,212	27,096 Added 135.48%	47,096 $273,000
Q2 2022 Aug 08, 2022	SELL	$4.02 - $10.43 $8,542 - $22,163	-2,125 Reduced 9.6%	20,000 $88,000
Q4 2021 Feb 02, 2022	BUY	$19.26 - $30.08 $426,127 - $665,520	22,125 New	22,125 $452,000
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $327,431 - $461,248	-13,171 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$22.3 - $36.02 $24,596 - $39,730	1,103 Added 9.14%	13,171 $461,000
Q1 2021 May 10, 2021	BUY	$26.38 - $51.15 $318,353 - $617,278	12,068 New	12,068 $402,000
Q4 2020 Feb 11, 2021	SELL	$10.5 - $28.5 $308,290 - $836,788	-29,361 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.61 - $9.87 $105,993 - $289,793	29,361 New	29,361 $290,000

259

256M

3.05M

1.71M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $346M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.